Janssen Receives CHMP Positive Opinion For Stelara® (Ustekinumab) Recommending Approval For The Treatment Of Moderately To Severely Active Crohn’s Disease In The European Union
- EMEA Innovative Medicine
- Janssen Receives CHMP Positive Opinion For Stelara® (Ustekinumab) Recommending Approval For The Treatment Of Moderately To Severely Active Crohn’s Disease In The European Union
Janssen Receives CHMP Positive Opinion For Stelara® (Ustekinumab) Recommending Approval For The Treatment Of Moderately To Severely Active Crohn’s Disease In The European Union
- X (Twitter)
Copy link